Architecture of TAF11/TAF13/TBP complex suggests novel regulation properties of general transcription factor TFIID

  1. Kapil Gupta
  2. Aleksandra A Watson
  3. Tiago Baptista
  4. Elisabeth Scheer
  5. Anna L Chambers
  6. Christine Koehler
  7. Juan Zou
  8. Ima Obong-Ebong
  9. Eaazhisai Kandiah
  10. Arturo Temblador
  11. Adam Round
  12. Eric Forest
  13. Petr Man
  14. Christoph Bieniossek
  15. Ernest D Laue
  16. Edward A Lemke
  17. Juri Rappsilber
  18. Carol V Robinson
  19. Didier Devys
  20. Làszlò Tora  Is a corresponding author
  21. Imre Berger  Is a corresponding author
  1. University of Bristol, United Kingdom
  2. University of Cambridge, United Kingdom
  3. Institut de Génétique et de Biologie Moléculaire et Cellulaire, IGBMC, France
  4. European Molecular Biology Laboratory, Germany
  5. University of Edinburgh, United Kingdom
  6. Physical and Theoretical Chemistry Laboratory, United Kingdom
  7. European Molecular Biology Laboratory, France
  8. Institut de Biologie Structurale, France
  9. Academy of Sciences of the Czech Republic, Czech Republic

Abstract

General transcription factor TFIID is a key component of RNA polymerase II transcription initiation. Human TFIID is a megadalton-sized complex comprising TATA-binding protein (TBP) and 13 TBP-associated factors (TAFs). TBP binds to core promoter DNA, recognizing the TATA-box. We identified a ternary complex formed by TBP and the histone fold (HF) domain-containing TFIID subunits TAF11 and TAF13. We demonstrate that TAF11/TAF13 competes for TBP binding with TATA-box DNA, and also with the N-terminal domain of TAF1 previously implicated in TATA-box mimicry. In an integrative approach combining crystal coordinates, biochemical analyses and data from cross-linking mass-spectrometry (CLMS), we determine the architecture of the TAF11/TAF13/TBP complex, revealing TAF11/TAF13 interaction with the DNA binding surface of TBP. We identify a highly conserved C-terminal TBP-interaction domain (CTID) in TAF13 which is essential for supporting cell growth. Our results thus have implications for cellular TFIID assembly and suggest a novel regulatory state for TFIID function.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Kapil Gupta

    School of Biochemistry, University of Bristol, Bristol, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Aleksandra A Watson

    Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Tiago Baptista

    Institut de Génétique et de Biologie Moléculaire et Cellulaire, IGBMC, Illkirch, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Elisabeth Scheer

    Institut de Génétique et de Biologie Moléculaire et Cellulaire, IGBMC, Illkirch, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Anna L Chambers

    School of Biochemistry, University of Bristol, Bristol, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8133-6240
  6. Christine Koehler

    European Molecular Biology Laboratory, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Juan Zou

    Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Ima Obong-Ebong

    Physical and Theoretical Chemistry Laboratory, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Eaazhisai Kandiah

    European Molecular Biology Laboratory, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Arturo Temblador

    European Molecular Biology Laboratory, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3076-6317
  11. Adam Round

    European Molecular Biology Laboratory, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Eric Forest

    Institut de Biologie Structurale, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Petr Man

    BioCeV - Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  14. Christoph Bieniossek

    European Molecular Biology Laboratory, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  15. Ernest D Laue

    Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7476-4148
  16. Edward A Lemke

    European Molecular Biology Laboratory, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  17. Juri Rappsilber

    Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  18. Carol V Robinson

    Physical and Theoretical Chemistry Laboratory, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  19. Didier Devys

    Institut de Génétique et de Biologie Moléculaire et Cellulaire, IGBMC, Illkirch, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9655-3512
  20. Làszlò Tora

    Institut de Génétique et de Biologie Moléculaire et Cellulaire, IGBMC, Illkirch, France
    For correspondence
    laszlo@igbmc.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7398-2250
  21. Imre Berger

    School of Biochemistry, University of Bristol, Bristol, United Kingdom
    For correspondence
    imre.berger@bristol.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7518-9045

Funding

Wellcome

  • Imre Berger

H2020 European Research Council (ERC-2013-340551)

  • Làszlò Tora

Research Councils UK

  • Imre Berger

Agence Nationale de la Recherche (ANR-13-BSV8-0021-03)

  • Imre Berger

Baden-Württemberg Stiftung

  • Imre Berger

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Cynthia Wolberger, Johns Hopkins University, United States

Version history

  1. Received: July 13, 2017
  2. Accepted: November 3, 2017
  3. Accepted Manuscript published: November 7, 2017 (version 1)
  4. Version of Record published: November 16, 2017 (version 2)

Copyright

© 2017, Gupta et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,467
    Page views
  • 551
    Downloads
  • 24
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Kapil Gupta
  2. Aleksandra A Watson
  3. Tiago Baptista
  4. Elisabeth Scheer
  5. Anna L Chambers
  6. Christine Koehler
  7. Juan Zou
  8. Ima Obong-Ebong
  9. Eaazhisai Kandiah
  10. Arturo Temblador
  11. Adam Round
  12. Eric Forest
  13. Petr Man
  14. Christoph Bieniossek
  15. Ernest D Laue
  16. Edward A Lemke
  17. Juri Rappsilber
  18. Carol V Robinson
  19. Didier Devys
  20. Làszlò Tora
  21. Imre Berger
(2017)
Architecture of TAF11/TAF13/TBP complex suggests novel regulation properties of general transcription factor TFIID
eLife 6:e30395.
https://doi.org/10.7554/eLife.30395

Share this article

https://doi.org/10.7554/eLife.30395

Further reading

    1. Biochemistry and Chemical Biology
    2. Medicine
    Giulia Leanza, Francesca Cannata ... Nicola Napoli
    Research Article

    Type 2 diabetes (T2D) is associated with higher fracture risk, despite normal or high bone mineral density. We reported that bone formation genes (SOST and RUNX2) and advanced glycation end-products (AGEs) were impaired in T2D. We investigated Wnt signaling regulation and its association with AGEs accumulation and bone strength in T2D from bone tissue of 15 T2D and 21 non-diabetic postmenopausal women undergoing hip arthroplasty. Bone histomorphometry revealed a trend of low mineralized volume in T2D (T2D 0.249% [0.156–0.366]) vs non-diabetic subjects 0.352% [0.269–0.454]; p=0.053, as well as reduced bone strength (T2D 21.60 MPa [13.46–30.10] vs non-diabetic subjects 76.24 MPa [26.81–132.9]; p=0.002). We also showed that gene expression of Wnt agonists LEF-1 (p=0.0136) and WNT10B (p=0.0302) were lower in T2D. Conversely, gene expression of WNT5A (p=0.0232), SOST (p<0.0001), and GSK3B (p=0.0456) were higher, while collagen (COL1A1) was lower in T2D (p=0.0482). AGEs content was associated with SOST and WNT5A (r=0.9231, p<0.0001; r=0.6751, p=0.0322), but inversely correlated with LEF-1 and COL1A1 (r=–0.7500, p=0.0255; r=–0.9762, p=0.0004). SOST was associated with glycemic control and disease duration (r=0.4846, p=0.0043; r=0.7107, p=0.00174), whereas WNT5A and GSK3B were only correlated with glycemic control (r=0.5589, p=0.0037; r=0.4901, p=0.0051). Finally, Young’s modulus was negatively correlated with SOST (r=−0.5675, p=0.0011), AXIN2 (r=−0.5523, p=0.0042), and SFRP5 (r=−0.4442, p=0.0437), while positively correlated with LEF-1 (r=0.4116, p=0.0295) and WNT10B (r=0.6697, p=0.0001). These findings suggest that Wnt signaling and AGEs could be the main determinants of bone fragility in T2D.

    1. Biochemistry and Chemical Biology
    Valentin Bohl, Nele Merret Hollmann ... Axel Mogk
    Research Article

    Heat stress can cause cell death by triggering the aggregation of essential proteins. In bacteria, aggregated proteins are rescued by the canonical Hsp70/AAA+ (ClpB) bi-chaperone disaggregase. Man-made, severe stress conditions applied during, e.g., food processing represent a novel threat for bacteria by exceeding the capacity of the Hsp70/ClpB system. Here, we report on the potent autonomous AAA+ disaggregase ClpL from Listeria monocytogenes that provides enhanced heat resistance to the food-borne pathogen enabling persistence in adverse environments. ClpL shows increased thermal stability and enhanced disaggregation power compared to Hsp70/ClpB, enabling it to withstand severe heat stress and to solubilize tight aggregates. ClpL binds to protein aggregates via aromatic residues present in its N-terminal domain (NTD) that adopts a partially folded and dynamic conformation. Target specificity is achieved by simultaneous interactions of multiple NTDs with the aggregate surface. ClpL shows remarkable structural plasticity by forming diverse higher assembly states through interacting ClpL rings. NTDs become largely sequestered upon ClpL ring interactions. Stabilizing ring assemblies by engineered disulfide bonds strongly reduces disaggregation activity, suggesting that they represent storage states.